Desk› Healthcare› Bal Pharma Ltd
Bal Pharma Ltd
Filing rhythm · 30 trading days
9 filings · 2 material · busiest 2026-08-10 and 2026-08-12
What it files
Filings
9 in the window
-
25 August 2026
GeneralClarification With Respect To Tentative Timeline For Utilization Of Net Proceeds Of Preferential Issue
This is in Continuation of Company earlier intimation made in connection with allotment of warrants , hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from ....
Company Update / General View filing →
-
13 August 2026
GeneralNewspaper Publications - Unaudited Financial Results 30Th June 2026 And IEPF Notice
In Continuation of Outcome of Board meeting dated August 12 2026 , Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani ....
Company Update / General View filing →
-
12 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12 2026
Board of directors of the Company met on Wednesday, August 12 2026 inter alia transacted the following business. 1. Considered and approved the unaudited Financial Results (Standalone ....
Board Meeting / Outcome of Board Meeting View filing →
-
12 August 2026
ResultsFinancial Result For The Quarter End 30Th June 2026
Enclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor
Result / Financial Results View filing →
-
10 August 2026
Postal BallotShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Outcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 , 2026
AGM/EGM / Postal Ballot View filing →
-
10 August 2026
Postal BallotShareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
AGM/EGM / Postal Ballot View filing →
-
5 August 2026
Board MeetingBoard Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters
Bal Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 and other ....
Board Meeting / Board Meeting View filing →
-
30 July 2026
GeneralDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 : Intimation Regarding Notice Of Postal Ballot
Company Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
Company Update / General View filing →
-
23 July 2026
GeneralIntimation Regarding Corrigendum To The Postal Ballot Notice
In Continuation of Postal Ballot Notice dated 09th July 2026 , Submitting Corrigendum as integral part to the Said Notice.
Company Update / General View filing →